ABO incompatibility is a risk factor for intestinal thrombotic microangiopathy (TMA) after allogeneic stem cell transplantation.

被引：0
|
作者：
Matsumoto, K [1 ]
Hirabayashi, N [1 ]
Kato, K [1 ]
Matsuyama, T [1 ]
机构：
[1] Nagoya First Hosp, Japanese Red Cross, Childrens Med Ctr, Nagoya, Aichi, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1235
引用
收藏
页码：349A / 349A
页数：1
相关论文
共 50 条
  • [1] ABO incompatibility as a prognostic factor in allogeneic stem cell transplantation.
    Benjamin, RJ
    McGurk, S
    Raiston, M
    Churchill, WH
    Antin, JH
    [J]. TRANSFUSION, 1998, 38 (10) : 70S - 70S
  • [2] Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantation.
    Henry, NL
    Li, SL
    Kim, HT
    Magee, C
    Alyea, E
    Ho, V
    Lee, SJ
    Soiffer, R
    Antin, JH
    Cutler, C
    [J]. BLOOD, 2004, 104 (11) : 508A - 508A
  • [3] Risk factor analysis for thrombotic microangiopathy after reduced intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae, H
    Yamane, T
    Kiyoyuki, H
    Takeoka, Y
    Sakamoto, E
    Nakane, T
    Nakamae, M
    Koh, KR
    Ohta, K
    Hino, M
    [J]. BLOOD, 2005, 106 (11) : 505A - 505A
  • [4] Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantation
    Cutler, C
    Henry, NL
    Li, S
    Kim, HT
    Magee, C
    Alyea, E
    Ho, V
    Soiffer, R
    Antin, J
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 4 - 4
  • [5] Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    Cutler, C
    Henry, NL
    Magee, C
    Li, SL
    Kim, HT
    Alyea, E
    Ho, V
    Lee, SJ
    Soiffer, R
    Antin, YH
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (07) : 551 - 557
  • [6] Thrombotic Microangiopathy in Allogeneic Stem Cell Transplantation in Childhood
    Erbey, Fatih
    Bayram, Ibrahim
    Kuskonmaz, Boris
    Yilmaz, Sema
    Cetin, Mualla
    Uckan, Duygu
    Tanyelil, Atila
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2010, 8 (03) : 237 - 244
  • [7] Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    Uderzo, Cornelio
    Bonanomi, Sonia
    Busca, Alessandro
    Renoldi, Mila
    Ferrari, Pierantonio
    Iacobelli, Massimo
    Morreale, Giuseppe
    Lanino, Edoardo
    Annaloro, Claudio
    Della Volpe, Aldo
    Alessandrino, Paolo
    Longoni, Daniela
    Locatelli, Franco
    Sangalli, Haidi
    Rovelli, Attilio
    [J]. TRANSPLANTATION, 2006, 82 (05) : 638 - 644
  • [8] Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation
    Nakamae, Hirohisa
    Yamane, Takahisa
    Hasegawa, Taro
    Nakamae, Mika
    Terada, Yoshiki
    Hagihara, Kiyoyuki
    Ohta, Kensuke
    Hino, Masayuki
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 525 - 531
  • [9] ABO-incompatibility -: Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation
    Stussi, G
    Muntwyler, J
    Passweg, J
    Seebach, L
    Schanz, U
    Gmür, J
    Gratwohl, A
    Seebach, JD
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (02) : 87 - 93
  • [10] Thrombotic microangiopathy (TMA) after renal transplantation
    Ardalan, Mohammadreza
    Shoja, Mohammadali Mohajel
    Tubbs, Shane
    Esmaili, Haydarali
    Noshad, Hamid
    Tayebi, Hamid
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 275 - 275
12345